Global Project Leader, Late Stage, Prescription Business @ Galderma
Project Leader, Early Stage @ Galderma R&D Sophia-Antipolis
Clinical Pharmacologist and Project Leader, Early Stage @ Galderma R&D Sophia-Antipolis
Group Leader Animal Pharmacology, Research @ Galderma R&D Sophia Antipolis
Team Leader, Research @ CIRD-Galderma R&D
Research Engineer @ Centre de Biochimie (UMR 134 CNRS), University of Nice-Sophia Antipolis, France
Michel Rivier's Education
Université Nice Sophia Antipolis
PhD, Molecular and Cellular Biology
Michel Rivier's Skills
Biotechnology
Pharmaceutical Industry
Secteur pharmaceutique
Biotechnologie
Sciences de la vie
Clinical Trials
Michel Rivier's Summary
Michel Rivier, based in France, is currently a Executive Director, Syneos Health Virtual Incubator-Accelerator, Clinical Pharm and BioA at Syneos Health, bringing experience from previous roles at Syneos Health, Syneos Health (Previously INC Research/inVentiv Health), Nestlé Skin Health and Galderma Laboratories LP, Fort Worth, TX USA. Michel Rivier holds a PhD, Molecular and Cellular Biology @ Université Nice Sophia Antipolis. With a robust skill set that includes Biotechnology, Pharmaceutical Industry, Secteur pharmaceutique, Biotechnologie, Sciences de la vie and more, Michel Rivier contributes valuable insights to the industry. Michel Rivier has 2 emails on RocketReach.